PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
62.10
ESG score near Healthcare median of 61.36. David Dodd would investigate if industry-standard ESG practices adequately address sector-specific risks.
59.34
Environmental score near Healthcare median of 58.53. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
63.14
Social score near Healthcare median of 63.49. David Dodd would investigate if industry-standard social practices adequately address stakeholder risks.
63.83
Governance score near Healthcare median of 62.04. David Dodd would investigate if industry-standard governance adequately protects shareholder interests.